#BioVaxys hashtag - Bluesky

@newsen.bsky.social

5 months ago

BioVaxys Technology Corp. Announces Significant Conversion of Debentures BioVaxys Technology Corp. has announced the conversion of outstanding unsecured convertible debentures, highlighting the company’s growth potential and future outlook.

BioVaxys Technology Corp. Announces Significant Conversion of Debentures #Canada #Vancouver #Debentures #BioVaxys #BioV

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

BioVaxys Technology Corp. Announces Successful Conversion of Debentures Into Shares BioVaxys Technology Corp. has announced the successful conversion of its unsecured convertible debentures, enhancing shareholder value through share issuance.

BioVaxys Technology Corp. Announces Successful Conversion of Debentures Into Shares #Canada #Vancouver #Immunotherapy #Debentures #BioVaxys

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

BioVaxys Technology Corp. Announces Conversion of Debentures and New Stock Options BioVaxys Technology Corp. has successfully converted its unsecured debentures, and announced the granting of new stock options to its directors and executives.

BioVaxys Technology Corp. Announces Conversion of Debentures and New Stock Options #Canada #Vancouver #stock_options #Debentures #BioVaxys

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

BioVaxys and SpayVac for Wildlife: Breakthrough Vaccine for Wildlife Fertility Control BioVaxys and SpayVac for Wildlife showcase impressive results from their single-dose immunocontraceptive vaccine, SpayVac. This advancement could significantly impact wildlife management.

BioVaxys and SpayVac for Wildlife: Breakthrough Vaccine for Wildlife Fertility Control #None #BioVaxys #Wildlife #SpayVac

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

BioVaxys Welcomes Former Sanofi Vaccines Executive to Board BioVaxys Technology Corp. has appointed Dr. James Tartaglia, a seasoned vaccine executive, to its Board of Directors, enhancing the company’s expertise.

BioVaxys Welcomes Former Sanofi Vaccines Executive to Board #Canada #Vancouver #BioVaxys #vaccines #James_Tartaglia

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

BioVaxys Technology Corp. Launches LIFE Offering to Enhance Research and Development Efforts BioVaxys Technology Corp. has announced a non-brokered private placement offering to raise up to $1.6 million, aimed at advancing innovative immunotherapy research.

BioVaxys Technology Corp. Launches LIFE Offering to Enhance Research and Development Efforts #Vancouver #Immunotherapy #BioVaxys #DPX_Technology

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

BioVaxys and Horizon Technology Update Asset Purchase Agreement in Major Move for Immunotherapies BioVaxys Technology Corp. announces amendments to the Asset Purchase Agreement with Horizon Technology Finance Corp, enhancing their acquisition strategy and financial milestones.

BioVaxys and Horizon Technology Update Asset Purchase Agreement in Major Move for Immunotherapies #Canada #Vancouver #BioVaxys #DPX_Technology #Horizon

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

BioVaxys Announces Successful Closure of Convertible Debenture Offering BioVaxys Technology Corp. has completed its non-brokered private placement of unsecured convertible debentures, raising $335,670 for advancing its projects.

BioVaxys Announces Successful Closure of Convertible Debenture Offering #Canada #Vancouver #biotechnology #BioVaxys #Debenture_Offering

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

BioVaxys Technology Corp. Announces Major Share Consolidation Strategy for Growth BioVaxys Technology Corp. reveals an upcoming share consolidation plan, aiming to enhance trading efficiency and navigate regulatory requirements successfully.

BioVaxys Technology Corp. Announces Major Share Consolidation Strategy for Growth #Canada #Vancouver #Immunotherapy #BioVaxys #Share_Consolidation

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

7 months ago

BioVaxys Technology Corp. Launches New Convertible Debenture Offering BioVaxys Technology Corp. has announced its plan to complete a non-brokered offering of unsecured convertible debentures totaling up to $500,000.

BioVaxys Technology Corp. Launches New Convertible Debenture Offering #Canada #Vancouver #Cancer_Immunotherapy #BioVaxys #Convertible_Debentures

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

BioVaxys Technology Corp. Extends Closing Date for Private Placement Offering BioVaxys Technology Corp. has announced an extension to the closing date for its brokered private placement offering, aiming to raise significant funds for research and development.

BioVaxys Technology Corp. Extends Closing Date for Private Placement Offering #Canada #Vancouver #Private_Placement #BioVaxys #BioVaxys_Technology

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

BioVaxys Partners with Enclave Capital for Private Placement Initiative BioVaxys Technology Corp. announces collaboration with Enclave Capital LLC for a brokered private placement offering aimed at financing its innovative immunotherapy projects.

BioVaxys Partners with Enclave Capital for Private Placement Initiative #Canada #Vancouver #Investment #BioVaxys #Enclave_Capital

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

9 months ago

BioVaxys Adjusts Terms for LIFE Offering, Anticipates Significant Gross Proceeds BioVaxys Technology Corp. has announced modifications to its LIFE offering, including updated share prices and a planned consolidation of common shares to achieve gross proceeds.

BioVaxys Adjusts Terms for LIFE Offering, Anticipates Significant Gross Proceeds #Canada #Vancouver #biotech #BioVaxys #LIFE_offering

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

BioVaxys and Horizon Technology Finance Corp Modify Partnership Terms for Asset Acquisition BioVaxys Technology Corp. and Horizon Technology Finance have updated their asset purchase agreement, including a significant reduction in milestone funding targets, enhancing cooperation in immunotherapy development.

BioVaxys and Horizon Technology Finance Corp Modify Partnership Terms for Asset Acquisition #Canada #Vancouver #Immunotherapy #BioVaxys #Horizon_Corp

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

BioVaxys and Sona Nanotech Forge Pioneering Cancer Treatment Collaboration The partnership between BioVaxys Technology Corp. and Sona Nanotech Inc. aims at innovating cancer treatment through a novel immunotherapy approach, combining advanced technologies.

BioVaxys and Sona Nanotech Forge Pioneering Cancer Treatment Collaboration #None #cancer_therapy #BioVaxys #Sona #Vancouver,_Halifax

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

11 months ago

BioVaxys and SpayVac Expand License for Aquaculture Success BioVaxys and SpayVac are collaborating to broaden their licensing agreement into aquaculture, focusing on innovative solutions for fish population control. This advancement holds significant potential for global revenue.

BioVaxys and SpayVac Expand License for Aquaculture Success #Canada #Vancouver #Aquaculture #BioVaxys #SpayVac

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioVaxys Technology Corp. Finalizes Debt Settlement for Better Cash Flow Management BioVaxys Technology Corp. has successfully negotiated a debt settlement agreement, converting $60,000 of debt into equity to enhance its cash flow.

BioVaxys Technology Corp. Finalizes Debt Settlement for Better Cash Flow Management #Canada #Vancouver #biotechnology #BioVaxys #Debt_Settlement

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioVaxys Technology Corp. Shares MCTO Progress Update and Investor Insights BioVaxys Technology Corp. delivers a bi-weekly update detailing the status of its management cease trade order (MCTO) and its ongoing efforts in compliance.

BioVaxys Technology Corp. Shares MCTO Progress Update and Investor Insights #Canada #Vancouver #biopharmaceuticals #BioVaxys #MCTO_Update

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioVaxys Technology Corp. Receives Management Cease Trade Order from BCSC Amid Financial Delays BioVaxys Technology Corp. has secured a Management Cease Trade Order from the BCSC due to delays in filing financial statements, impacting its executive trading activities.

BioVaxys Technology Corp. Receives Management Cease Trade Order from BCSC Amid Financial Delays #Canada #Vancouver #BioVaxys #MCTO #BCSC

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioVaxys Finalizes Debt Settlement and Extends Private Placement Closing Deadline BioVaxys Technology Corp. has announced a debt settlement agreement along with an extension on its private placement closing date amid ongoing financial maneuvers.

BioVaxys Finalizes Debt Settlement and Extends Private Placement Closing Deadline #Canada #Vancouver #Private_Placement #BioVaxys #Debt_Settlement

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioVaxys Technology Coping with Delays in Annual Financial Filings BioVaxys Technology Corp. faces a short-term delay in filing its audited financial statements due to recent acquisitions and auditor review complexities.

BioVaxys Technology Coping with Delays in Annual Financial Filings #Canada #Vancouver #BioVaxys #CFO_Certifications #Management_Cease_Trade_Order

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioVaxys Announces New Closing Date for Private Placement Funding Opportunity BioVaxys Technology Corp. has extended the closing date for its private placement offering, allowing more time for investor participation.

BioVaxys Announces New Closing Date for Private Placement Funding Opportunity #Canada #Vancouver #Immunotherapy #Private_Placement #BioVaxys

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioVaxys Technology Corp. Extends Closing Date for Private Placement Offering to Attract More Investors BioVaxys Technology Corp. announces an extension to the closing date for its non-brokered private placement, aimed at boosting investor participation.

BioVaxys Technology Corp. Extends Closing Date for Private Placement Offering to Attract More Investors #Canada #Vancouver #Immunotherapy #BioVaxys #DPX_Technology

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioVaxys Aims to Transform mRNA Vaccine Delivery with DPX Technology for Major Market Growth BioVaxys Technology Corp. is setting its sights on revolutionizing mRNA vaccine delivery with its DPX™ platform, poised for substantial market growth by 2030.

BioVaxys Aims to Transform mRNA Vaccine Delivery with DPX Technology for Major Market Growth #Canada #Vancouver #BioVaxys #DPX_Technology #mRNA_vaccines

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioVaxys Technology Corp. Invites Investors to Emerging Growth Conference on January 16, 2025 BioVaxys Technology Corp. will present its innovative vaccine developments at the Emerging Growth Conference, inviting interaction with investors and analysts.

BioVaxys Technology Corp. Invites Investors to Emerging Growth Conference on January 16, 2025 #Canada #Vancouver #BioVaxys #Emerging_Growth #vaccines

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioVaxys Technology Corp. Completes Third Tranche of Private Placement Funding BioVaxys Technology Corp. successfully closes its third tranche of a private placement, raising $537,500. The funds are designated for working capital and strategic initiatives.

BioVaxys Technology Corp. Completes Third Tranche of Private Placement Funding #Canada #Vancouver #Private_Placement #BioVaxys #DPX_Technology